Clofazimine
Top View
- Failure with Acquired Resistance of an Optimised Bedaquiline-Based Treatment Regimen for Pulmonary Mycobacterium Avium Complex Disease
- CYCLOSERINE, PRETOMANID and SIRTURO®
- Combinations Involving Dapsone, Rifampin, Clofazimine, and Ethionamide in the Treatment of M
- Development of New Tuberculosis Drug Regimens
- Estonian Statistics on Medicines 2017 1/42
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- The Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in Singapore: Are Patients from South-East Asia Eligible?
- Failure with Acquired Resistance of an Optimised Bedaquiline-Based Treatment Regimen for Pulmonary Mycobacterium Avium Complex Disease
- A Review on Agents for the Treatment of Leprosy Infection
- Effectiveness and Safety of Clofazimine In€Multidrug-Resistant Tuberculosis
- Antiinfectives Targeting Enzymes and the Proton Motive Force
- WHO Treatment Guidelines for Drug- Resistant Tuberculosis
- EML Application Form Commented-Explained.Docx
- Evaluation of High-Dose Rifapentine Plus Clofazimine in the First-Line Regimen for Tuberculosis in the Mouse Model of Chemotherapy
- Drug-Resistant Leprosy: Monitoring and Current Status
- Discovery of a Highly Potent Novel Rifampicin Analog by Preparing A
- Who-Pq Recommended Summary of Product Characteristics
- Anti-Leprosy Drugs: Modes of Action and Mechanisms of Resistance in Mycobacterium Leprae